Mesbold股价上涨10%

· rttnews.com

Mesoblast Limited (MESO) 股价周一上涨1.54美元,至17.14美元,涨幅9.91%,此前该公司宣布完成用于治疗慢性腰痛的rexlemestrocel-L关键性3期试验的患者治疗。

Mesoblast Limited (MESO) shares rose $1.54, or 9.91 percent, to $17.14 on Monday, possibly following the company's announcement that it had completed patient tr...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI